Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor Maven Capital Partners (Maven) and £1 million from existing investor, Gresham House Ventures (Gresham House).
Metrion Biosciences closes £3.7m new equity financing
- Post author:
- Post published:December 20, 2023
- Post category:uncategorized